Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high‐grade carcinomas support different pathogenetic pathways

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Pathology

• Publication date

  2005-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/path.1817PMID 16021676
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis: A Mutational Analysis With Immunohistochemical Correlation

  2005cited by this paper
• Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

  2004cited by this paper
• Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images.

  2004cited by this paper
• Borderline ovarian tumors: key points and workshop summary.

  2004cited by this paper
• Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts

  2003cited by this paper
• Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.

  2003cited by this paper
• Detection of Numerical Chromosomal Abnormalities in Epithelial Ovarian Neoplasms by Fluorescence In Situ Hybridization (Fish) and a Review of the Current Literature

  2002cited by this paper
• Serous Borderline Tumors of the Ovary: A Long-Term Follow-Up Study of 137 Cases, Including 18 With a Micropapillary Pattern and 20 With Microinvasion

  2002cited by this paper
• Ovulation-Induced DNA Damage in Ovarian Surface Epithelial Cells of Ewes: Prospective Regulatory Mechanisms of Repair/Survival and Apoptosis1

  2001cited by this paper
• Ovarian surface epithelium: biology, endocrinology, and pathology.

  2001influential reference
• Interphase cytogenetics in oncocytic adenomas and carcinomas of the thyroid gland.

  2000cited by this paper
• Interphase fluorescence in situ hybridization studies of ovarian adenocarcinomas using the midisatellite probe.

  1999cited by this paper
• Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours

  1999cited by this paper
• Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer.

  1999cited by this paper
• Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors.

  1999cited by this paper
• DNA copy number losses in human neoplasms.

  1999cited by this paper
• The biology of ovarian cancer.

  1998cited by this paper
• Genetics and ovarian carcinoma.

  1998cited by this paper
• Role of the X chromosome in cancer.

  1996cited by this paper
• Early involvement of 6q in surface epithelial ovarian tumors.

  1996cited by this paper
• Potential role of the inactivated X chromosome in ovarian epithelial tumor development.

  1996cited by this paper
• Frequent microsatellite instability in epithelial borderline ovarian tumors.

  1996cited by this paper
• Detection of numerical chromosome anomalies in interphase cells of ovarian carcinomas using fluorescence in situ hybridization

  1996cited by this paper
• Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas.

  1996cited by this paper
• Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.

  1995cited by this paper
• Early de novo ovarian carcinoma. A study of fourteen cases

  1994cited by this paper
• Morphologic precursors of ovarian epithelial tumors.

  1993cited by this paper
• Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.

  1993cited by this paper
• Contralateral Ovary in Unilateral Ovarian Carcinoma: A Search for Preneoplastic Lesions

  1993cited by this paper
• National survey of ovarian carcinoma VI: Critical assessment of Current International Federation of Gynecology and Obstetrics Staging System

  1993cited by this paper
• Morphologic Precursors of Ovarian Epithelial Tumors

  1993cited by this paper
• Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma.

  1992cited by this paper
• Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers.

  1991cited by this paper

• High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors

  2023cites this paper
• Рецепторный статус опухолевых клеток и механизмы нарушения тканевого гомеостаза при канцерогенезе серозного овариального рака

  2019cites this paper
• Receptor Status of Tumor Cells and Mechanisms of Disorders of Tissue Homeostasis in Carcinogenesis of Serous Ovarian Cancer

  2019cites this paper
• Serous Neoplasms of the Ovary

  2019cites this paper
• Tubal Origin of “Ovarian” Low-Grade Serous Carcinoma: A Gene Expression Profile Study

  2019cites this paper
• Pathology of Epithelial Ovarian Tumors

  2017cites this paper
• Age related increase in mTOR activity contributes to the pathological changes in ovarian surface epithelium

  2016cites this paper
• Different expression of S 100 A 11 in normal ovarian epithelium , serous benign / borderline tumor , and low-grade serous ovarian carcinoma

  2016cites this paper
• Two Types of Ovarian Cortical Inclusion Cysts: Proposed Origin and Possible Role in Ovarian Serous Carcinogenesis

  2015cites this paper
• Tubal origin of ovarian low-grade serous carcinoma.

  2013cites this paper
• Mutation analysis of papillary tubal hyperplasia associated with ovarian atypical proliferative serous tumor and low-grade serous carcinoma.

  2013cites this paper
• Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis

  2012cites this paper
• Fallopian tube as main source for ovarian and pelvic (non-endometrial) serous carcinomas.

  2012cites this paper
• Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification?

  2011cites this paper
• Tubal origin of ‘ovarian’ low-grade serous carcinoma

  2011cites this paper
• The role of Hoxa7 and Pax8 in epithelial ovarian cancer differentiation

  2010cites this paper
• Biomolecular pathogenesis of borderline ovarian tumors: focusing target discovery through proteogenomics.

  2010cites this paper
• Müllerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics

  2010cites this paper
• Serous psammocarcinoma of the ovary and peritoneum: two case reports and review of the literature

  2009cites this paper
• CHAPTER 12 – Peritoneal Washings and Ovary

  2008cites this paper
• Lessons from BRCA: The Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer

  2007cites this paper
• Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship

  2007cites this paper
• Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses.

  2006cites this paper
• TUMOR BORDERLINE MUCINOSO OVÁRICO GIGANTE CON MICROINVASIÓN

  2006cites this paper
• Higher frequency of chromosomal aberrations in ovarian endometriosis compared to extragonadal endometriosis: a possible link to endometrioid adenocarcinoma

  2006cites this paper